A presentation by Mohan P. Joshi, Principal Technical Advisor and Lead for Pharmaceutical Services, SIAPS. Presented at a side event during the 2018 Prince Mahidol Awards Conference on the theme “Monitoring and Improving Medicines Quality through AMR National Action Plans”, organized by USP, USAID, the Thai Food and Drug Authority, and the Thai Department of Medical Sciences on January 29, 2018 in Bangkok, Thailand.
Advancing the Antimicrobial Drug Quality Agenda through Coalition Building: Lessons from AMR Response
Training on Pharmaceutical and Medical Commodities Supply Chain Management in Humanitarian Response Settings
Most NGOs and partners who work with OFDA face significant challenges in pharmaceutical procurement and supply chain management (SCM) as well as difficulties complying with OFDA policies, procedures, and funding/donation requirements. OFDA seeks to ensure excellence in its operations and programs and continues to push for significant changes to establish a humanitarian aid system that is more nimble, effective, and accountable. To accomplish this, OFDA requested technical assistance from SIAPS to develop training materials and facilitate two rounds of training for staff of its collaborating humanitarian aid partners and local and international NGOs. This training will help to ensure that appropriate procurement and SCM is implemented for the delivery of quality-assured pharmaceuticals and medical commodities to conflict-affected, internal, and cross-border displaced people. The objectives of the training program were to build the capacity of humanitarian aid partner staff on humanitarian SCM for the effective delivery of pharmaceuticals and medical commodities.
A presentation by Mohan P. Joshi, Principal Technical Advisor and Lead for Pharmaceutical Services, SIAPS, at USAID in Arlington, VA on November 9 2017.
Antimicrobial resistance (AMR) is one of the world’s most pressing and urgent global health threats— one that could erode the current progress against tuberculosis (TB), malaria, HIV/AIDS, and many other infectious diseases. AMR poses an enormous threat to the safety and feasibility of complex surgeries and procedures like organ transplantation and chemotherapy, but could also make childbirth, minor infections, and hospital stays more perilous. While AMR has emerged as a critical issue at the global level, current efforts to address AMR are insufficient to curb its spread. Immediate, cross-cutting, and multidisciplinary action is required to adequately address the multidimensional drivers of AMR. In the health sector, strengthening the systems through which health services and medicines are provided is a prerequisite to making progress against AMR.
This technical program update discusses how the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, funded by the US Agency for International Development (USAID), is working to address AMR through a health system strengthening approach with interventions spanning the global, regional, national, and local levels.
With the shift from a disease landscape that focuses on the treatment of acute and short-term illnesses to one that faces an increasing burden of chronic diseases that may require life-long medicine use, the role of medicines in ensuring a healthy population is more important than ever.
However,even when medicines are available, patients may not take them as directed. In other words, they may not adhere to the treatment prescribed to them. This problem is surprisingly widespread. Several studies have estimated that in developed countries, only approximately 50% of patients who suffer from chronic diseases take their medicines as directed.
This document suggests a health systems strengthening (HSS) approach to addressing
medication adherence issues, with a particular emphasis on its application in low- and middle-income settings. Chapter 2 reviews the importance of considering health systems in improving medication adherence and introduces a system-based framework, while Chapters 3–5 discuss approaches, interventions, and activities that span the health system as described at the
macro, meso, and micro levels and provide implementation examples.
Joshi MP. Containing antimicrobial resistance to realize the goals of universal health coverage. Oral presentation at the Ecumenical Pharmaceutical Network (EPN) Forum 2016, Tubingen, Germany. May 18-21, 2016.
“Continuing Pharmaceutical Education: Guide to Establishing Quality Assured and Accredited Programs”
Joshi, M.P.; Andualem, T.; Phulu, B.; Mpundu, M.; Ludman, M. Country and regional level advocacy and coalition-building against antimicrobial resistance. Oral presentation at the 143rd American Public Health Association (APHA) Annual Meeting and Expo, Chicago, IL, USA.
Briggs J, Joshi MP, Yeager B, Diarra S. Ensuring access to and appropriate use of medicines for iCCM: It takes a system. Oral presentation at the 143rd American Public Health Association (APHA) Annual Meeting and Expo, Chicago, IL, USA. November 3, 2015.
About one-third to one-half of all antibiotics used in hospitals is for surgical prophylaxis; however, 30 to 90 percent of this use is inappropriate. The Jordan Food and Drug Administration (JFDA) recently conducted a study in Jordanian hospitals that provided data on surgical antibiotic prophylaxis practices, including for cesarean section. The study findings indicated that these practices could be improved. In the context of the JFDA’s study findings and recommendations, the U.S. Agency for International Development-funded Strengthening Pharmaceutical Systems (SPS) program, and its follow-on Systems for Improved Access to Pharmaceuticals and Services (SIAPS), provided technical assistance to help strengthen practices regarding antibiotic prophylaxis for cesarean sections at three Ministry of Health (MOH) hospitals in Jordan—Prince Hussein Hospital, Prince Faisal Hospital, and Dr. Jameel Al Totanji Hospital.
- The Use of Pharmaceutical Information for Decision Making in Namibia's National ART Program: Assessment Report
SIAPS conducted this assessment to determine the extent to which pharmaceutical information generated from the Electronic Dispensing Tool (EDT) and […]
The Directorate of Drugs and Medical Supplies (DDMS) plays a key role in providing technical guidance and setting strategic direction […]
- Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program Inventory of Key Technical Resources
The main purpose of this inventory is to serve as a reference to help stakeholders working in the pharmaceutical sector […]